Healthcare provider profile · identity verified

Benjamin Arthur Flinn, MD

Family Practice · BERLIN, VT · NPI 1134740962

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	336	117
Gabapentin	Gabapentin	165	49
Omeprazole	Omeprazole	139	50
Lisinopril	Lisinopril	136	50
Amlodipine Besylate	Amlodipine Besylate	114	46
Losartan Potassium	Losartan Potassium	105	34
Levothyroxine Sodium	Levothyroxine Sodium	104	40
Duloxetine Hcl	Duloxetine Hcl	84	18
Albuterol Sulfate Hfa	Albuterol Sulfate	82	36
Metoprolol Succinate	Metoprolol Succinate	71	26
Hydrochlorothiazide	Hydrochlorothiazide	69	28
Pantoprazole Sodium	Pantoprazole Sodium	65	24
Eliquis	Apixaban	61	20
Famotidine	Famotidine	60	28
Sertraline Hcl	Sertraline Hcl	52	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	20
Furosemide	Furosemide	51	22
Metformin Hcl Er	Metformin Hcl	51	18
Clonazepam	Clonazepam	48	suppressed
Alendronate Sodium	Alendronate Sodium	47	16
Rosuvastatin Calcium	Rosuvastatin Calcium	42	17
Lovastatin	Lovastatin	40	11
Metoprolol Tartrate	Metoprolol Tartrate	38	12
Enalapril Maleate	Enalapril Maleate	37	suppressed
Mirtazapine	Mirtazapine	37	17
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	11
Allopurinol	Allopurinol	31	11
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Bupropion Xl	Bupropion Hcl	29	12
Fluticasone Propionate	Fluticasone Propionate	29	18
Trazodone Hcl	Trazodone Hcl	29	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Glipizide Er	Glipizide	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Simvastatin	Simvastatin	27	12
Ozempic	Semaglutide	26	suppressed
Carvedilol	Carvedilol	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	13
Meloxicam	Meloxicam	25	13
Metformin Hcl	Metformin Hcl	25	11
Xarelto	Rivaroxaban	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Lorazepam	Lorazepam	23	14
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Synthroid	Levothyroxine Sodium	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Carbamazepine	Carbamazepine	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error